Fig. 2

A 45-year-old female, diagnosed with triple-negative breast cancer was on opioid medications, but did not experience any relief in pain. Her baseline pain scoring (VASmax) was 8/10. Baseline [⁶⁸Ga]Ga-DOTA-ZOL PET/CT (a) was conducted followed by administration of 1.3 GBq of [¹⁷⁷Lu]Lu-DOTA-ZOL. Twenty-four-hour post-administration, post-therapy 24-h anterior and posterior whole body scan (b) demonstrate avid [¹⁷⁷Lu]Lu-DOTA-ZOL uptake in multiple skeletal sites